IVIGILANCE SQUARE
LIVE

Serial Number

99408746

Owner

SELTA SQUARE Inc.

Attorney

Young Joon Jung

Filing Date

Sep 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IVIGILANCE SQUARE Trademark

Serial Number: 99408746

IVIGILANCE SQUARE is a trademark filed by SELTA SQUARE Inc. on September 23, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SELTA SQUARE Inc. (2 trademarks)

C-19, #804, 8th Floor, 124, Unjung-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13466 , KR

Entity Type: 99

Trademark Details

Filing Date

September 23, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Educational services, namely, conducting classes, seminars, conferences, workshops in the fields of medicine and pharmacy; Medical training and education services, namely, conferences, congresses, seminars, workshops and symposiums in the medicine and pharmacy fields; Medical education services, namely, providing live and on-line education courses in the field of medicine and pharmacy; Educational services, namely, organizing, arranging, and conducting in-person educational forums in the fields of clinical research and clinical trial operations, clinical research site management, and conduct of clinicians

Medical services; Managed healthcare services; Provision of medical information; Provision of information in the field of medicine; Consumer-authorized clinical laboratory testing services being medical testing services that report results directly to the patient; Monitoring of clinical trial patients being medical care

Downloadable and recorded software for detecting, evaluating, analyzing, monitoring, processing, reporting, and managing pharmaceutical-related clinical data; Downloadable and recorded software for tracking, evaluating, analyzing, monitoring, processing, reporting, and managing drug safety using clinical data; Downloadable and recorded software for detecting, evaluating, analyzing, monitoring, processing, interpreting, reporting, managing, and preventing adverse drug reactions or side effects using clinical data; Downloadable and recorded pharmacovigilance software for monitoring and managing the safety of pharmaceutical products using clinical data; Downloadable computer programs for the design and management of clinical trials and research; Downloadable and recorded mobile device software for the design and management of clinical trials and research; Downloadable and recorded analytical software for analyzing clinical trial data

Research and development in the field of biotechnology; Computer programming services in the medical field; Consulting services relating to testing, inspection, and research of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Clinical research services in the field of pharmaceuticals; Development of computer software for processing and analyzing clinical data; Medical research services, namely, conducting clinical trial research for others and clinical trial research management for others in the field of pharmaceuticals; Software as a service (SaaS) services featuring software for delivering streamlined clinical trial information and improving communication among stakeholders in clinical trials; Providing medical and scientific research information in the field of clinical trials for delivering streamlined clinical trial information and improving communication among stakeholders in clinical trials; Consulting services in the field of medical research in the nature of conducting clinical trials for others

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2026 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 26, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2026 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 23, 2025 MAFR
NEW APPLICATION ENTERED
Sep 23, 2025 NWAP